Vicore Pharma
Founded 2009 · 61 employees on LinkedIn · 1 known investors
Find your way into Vicore Pharma
Sign up to see every warm intro you have to Vicore Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vicore Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vicore Pharma is a clinical-stage biopharmaceutical company developing disease-modifying treatments for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis. The company's lead program, buloxibutid, is an oral small molecule in Phase 2b clinical trials.
Investors · 1
Frequently asked questions
- What does Vicore Pharma do?
- Vicore Pharma is a clinical-stage biopharmaceutical company developing disease-modifying treatments for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis. The company's lead program, buloxibutid, is an oral small molecule in Phase 2b clinical trials.
- Who are Vicore Pharma's investors?
- Vicore Pharma's investors include HealthCap.

